Found 0 matching trials
Lenalidomide Plus R-CHOP for CNS Relapse Prophylaxis in Diffuse Large B-cell Lymphoma PHASE2 This is an open-label, multicenter, phase 2 trial to explore the efficacy a...
Show More Learn More & Join Trial
A Phase III Clinical Trial of High-dose Rituximab (500mg/m²) Combined With CHOP Regimen in the Treatment of Male Patient With Newly Diagnosed Advanced DLBCL PHASE3 Comparison of MODIFIED progression-free survival (Modified-PFS) in high-dos...
Show More Location
Multiple Locations
Learn More & Join Trial
Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma PHASE2 This is a prospective multicenter phase II pilot trial designed with the pu...
Show More Location
Divisione di Ematologia Osp. SS. Antonio e Biagio
Learn More & Join Trial
R-CHOP14 or R-CHOP21 &Consolidation PET-Oriented Radiotherapy (RT) in DLBCL Patients PHASE2 Prospective, multicentre phase II study with R-CHOP- 14 or R-CHOP-21 \& con...
Show More Learn More & Join Trial
Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma PHASE2 A Phase II, open-label, two-arm, multicenter study evaluating the combinati...
Show More Location
Zuckerberg San Francisco General
Learn More & Join Trial
Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma PHASE2 The purpose of the study is to assess the efficacy of the association of Le...
Show More Location
Institut Bergonié
Learn More & Join Trial
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma PHASE1 This is a Phase 1b study consisting of 2 parts: a dose escalation (Part 1) ...
Show More Status
Active Not Recruiting
Location
Local Institution - 162
Learn More & Join Trial
Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma PHASE3 This is an open label, multi-center, international, randomized phase III tr...
Show More Location
INSTITUT JULES BORDET - Service Hématologie
Learn More & Join Trial
Lenalidomide and R-CHOP in B-cell Lymphoma PHASE1 The purpose of the study is to determine the recommended dose (RD) of lenal...
Show More Learn More & Join Trial